Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...

Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...

Key Takeaways The number of people taking GLP-1 drugs to lose weight more than tripled in recent yearsThe percentage of ...

Drugs like Ozempic, Wegovy, and Saxenda have become hugely popular. But could they cause psychological side effects in their ...

Meghan Trainor revealed which weight-loss drug she has used as she addressed criticism and concern about her appearance in an ...

Whether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid hearing about the sudden ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

In addition to the injectable medication, which is primarily used to treat type 2 diabetes, the “Trainwreck” star has a new ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as  GLP-1s.

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...